https://www.selleckchem.com/pr....oducts/deruxtecan.ht
y marker of interest. A larger randomized controlled trial aimed at measuring both biological and clinical outcomes is indicated. Clinical Trial Registration ClinicalTrials.gov, Identifier NCT02723344.Background Injuries from exposure to explosions rose dramatically during the Iraq and Afghanistan wars, which motivated investigation of blast-related neurotrauma. We have undertaken human studies involving military "breachers" -exposed to controlled, low-level blast during a 3-days explosive breaching course. Methods We screened epigen
Curtir
Comentario
Compartilhar
